Modular Medical (NASDAQ:MODD – Get Free Report) is one of 217 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its rivals? We will compare Modular Medical to related businesses based on the strength of its earnings, dividends, valuation, institutional ownership, analyst recommendations, risk and profitability.
Volatility & Risk
Modular Medical has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500. Comparatively, Modular Medical’s rivals have a beta of 1.30, meaning that their average share price is 30% more volatile than the S&P 500.
Profitability
This table compares Modular Medical and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Modular Medical | N/A | -159.51% | -137.42% |
| Modular Medical Competitors | -624.99% | -324.14% | -29.74% |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Modular Medical | 0 | 0 | 2 | 0 | 3.00 |
| Modular Medical Competitors | 1251 | 3535 | 7263 | 195 | 2.52 |
Modular Medical presently has a consensus price target of $4.25, indicating a potential upside of 266.38%. As a group, “Surgical & medical instruments” companies have a potential upside of 41.42%. Given Modular Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Modular Medical is more favorable than its rivals.
Institutional & Insider Ownership
29.4% of Modular Medical shares are held by institutional investors. Comparatively, 44.5% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 59.2% of Modular Medical shares are held by company insiders. Comparatively, 14.5% of shares of all “Surgical & medical instruments” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Modular Medical and its rivals top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Modular Medical | N/A | -$13.88 million | -0.98 |
| Modular Medical Competitors | $1.10 billion | $78.88 million | 27.86 |
Modular Medical’s rivals have higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Summary
Modular Medical rivals beat Modular Medical on 7 of the 13 factors compared.
Modular Medical Company Profile
Modular Medical, Inc. operates as a development stage medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for diabetes. The company was founded in 1998 and is headquartered in San Diego, California.
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.
